PAMU
INO icon

Pictet Asset Management (UK)’s Inovio Pharmaceuticals INO Stock Holding History

Pictet Asset Management (UK)’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$146K Sell
1,308
-17,490
-93% -$1.68M ﹤0.01% 1670
2021
Q1 		$2.09M Buy
18,798
+4,106
+28% +$540K ﹤0.01% 975
2020
Q4 		$1.56M Sell
14,692
-1,367
-9% -$182K ﹤0.01% 980
2020
Q3 		$2.23M Buy
16,059
+1,700
+12% +$354K ﹤0.01% 882
2020
Q2 		$4.64M Buy
+14,359
New +$2.31M 0.01% 706

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pictet Asset Management (UK)'s INO Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Inovio Pharmaceuticals (INO) stake by 93% in Q2 2021, selling an estimated $1.68M and leaving 1,308 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

Pictet Asset Management (UK) first reported a position in INO in Q2 2020 and has held it in 5 quarters since. The position peaked at $4.64M in Q2 2020. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

  • Pictet Asset Management (UK) held 1,308 shares of Inovio Pharmaceuticals worth $146K as of Q2 2021.
  • Pictet Asset Management (UK) sold 17,490 Inovio Pharmaceuticals shares in Q2 2021, an estimated $1.68M.
  • Inovio Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1670 holding.
  • Pictet Asset Management (UK) first reported a position in Inovio Pharmaceuticals in Q2 2020 and has held it in 5 quarters since.
  • Pictet Asset Management (UK)'s Inovio Pharmaceuticals position peaked at $4.64M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.